Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: Experiences in a developing country

Pediatric Pulmonology

Volumn 27, Issue 5, 1999, Pages 312-317

  Da Costa, David E ^a   Pai, M G K ^a   Al Khusaiby, Saleh M ^a  

^a Postal Code 111 ^*

Author keywords

Newborn; Randomized clinical trial; Respiratory distress syndrome; Surfactant

Indexed keywords

LUNG SURFACTANT;

ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD OXYGENATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPING COUNTRY; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; TREATMENT PLANNING;

EID: 0032947210     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199905)27:5<312::AID-PPUL3>3.0.CO;2-N     Document Type: Article

References (25)

1. Soll RF, McQueen MC. Respiratory distress syndrome. In: Sinclair JC, Bracken MB, editors. Effective care of the newborn infant. Oxford University Press; 1992. p 325-358.
2. Liechtyt A, Donovan E, Purohit D. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight infants with respiratory distress. Pediatrics 1991;88:19-28.
3. Shapiro DL, Notter RH, Morin FC. Double blind randomized trial of calf lung surfactant extract administered at birth to very premature infants for the prevention of respiratory distress syndrome. Pediatrics 1985;76:593-599.
4. Hoekstra RE, Jackson JC, Myers TE. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatrics 1991; 88:10-18.
5. Corbet A, Bucciarelli R, Goldman S, Mammel M, Wold D, Long W, American Exosurf Pediatric Study Group. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. J Pediatr 1991;118:277-284.
6. Long W, Corbet A, Cotton R, Courtney S, McGuiness G, Walter D, Watts J, Smyth J, Bard H, Chernick V. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with re-spiratory distress syndrome. N Engl J Med 1991;325:1696-1703.
7. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birthweights less than 1500 gm. J Pediatr 1978; 92:529-534.
8. Burroughs Wellcome. Exosurf Neonatal (colfosceril palmitate, cetyl alcohol, tyloxapol) for intratrachael suspension package insert. Research Triangle Park, NC: Burroughs Wellcome; product insert, 1990.
9. Ross Laboratories. Survanta. Beractant intratracheal sterile suspension. Columbus, OH: Ross Laboratories; product insert, 1994.
10. Ortiz RM, Cilley RE, Bartlett RH. Extracorporeal membrane oxygenation in pediatric respiratory failure. Pediatr Clin North Am 1987;34:39-46.
11. CDC, Atlanta, Georgia, WHO, Geneva, Switzerland. Epi Info. 1994; version 6.02.
12. Ikegami M, Jobe A, Jacobs H, Jones SJ. Sequential treatments of premature lambs with an artificial surfactant and natural surfactant. J Clin Invest 1981;68:491-496.
13. Cummings JJ, Holm BA, Hudak ML, Hudak BB, Ferguson WH, Egan EA. A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. Am Rev Respir Dis 1992;145:999-1004.
14. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcome in premature infants: prediction from the oxygen requirements in the neonatal period. Pediatrics 1988;82:527-532.
15. Horbar JD, Soll RF, Schachinger M, Kewitz G, Versmold HT, Lindner W, Duc G, Mieth D, Linderkamp O, Zilow EP. A European multicenter randomized controlled trial of single dose surfactant therapy for idiopathic respiratory distress syndrome. Eur J Pediatr 1990;149:416-423.
16. Lang MJ, Hall RT, Reddy NS, Kurth CG, Merrit TM. A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants. J Pediatr 1990;116:295-300.
17. Canadian Exosurf Pediatric Study Group. Effects of two rescue doses of Exosurf Pediatric in 342 750-1249 gram infants. Pediatr Res 1990;27:200.
18. Vermont Oxford Neonatal Network. A multicenter randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Pediatrics 1996;97:1-6.
19. Jobe A, Ikegami M. Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis 1987;136:1256-1275.
20. Notter R. Physical chemistry and physiological activity of pulmonary surfactants. In: Shapiro D, Notter R, editors. Surfactant replacement therapy. New York: Alan R. Liss; 1989. p 19-70.
21. Schurch S. Surface tension properties of surfactant. Clin Perinatol 1993;20:669-682.
22. Horbar JD, Wright LL, Soll RF, Wright EC, Fanaraoff AA, Korones SB, Shankaran S, Oh W, Fletcher BD, Bauer CR. A multi-center randomized trial comparing two surfactants for the treat-ment of neonalal respiratory distress syndrome. J Pediatr 1993; 123:757-766.
23. Hudak ML, Farrell EE, Rosenberg AA, Jung AL, Auten RL, Durand DJ, Horgan MJ, Buckwald S, Balcastro MR, Donohue PK. A multicenter randomized masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome. J Pediatr 1996;128:396-406.
24. Tarnow-Mordi WO, Soll RF. Artificial versus natural surfactant - can we base clinical practice on a firm scientific footing? Eur J Pediatr 1994;153:17-21.
25. Medori R, Tritchler HJ, LeBlanc A. Fatal familial insomnia: a prior disease with a mutation at codin 178 of the prion gene. N Engl J Med 1992;326:444-449.